🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06665438
Recruiting Phase 3

Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery

NCT06665438 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 3
Started
2024-12-01
Last updated
2025-04-22

Condition(s) studied

Post Operative Analgesia

Investigational drug(s) / intervention(s)

Normal Saline (Placebo)Bupivacaine 0.25% →Dexmedetomidine →

Normal Saline (Placebo): the 18 ml of normal saline will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure

Bupivacaine 0.25%: the 18ml 0.25% bupivacaine. will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure

Dexmedetomidine: Dexmedetomidine 1 μg/kg will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure.

Study summary

The aim of this study to compare the analgesic effects of intraarticular dexmedetomidine added to bupivacaine with those of bupivacaine alone after knee arthroscopy

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * ASA I-II patients * Either sex * Aged 18-65 years * Candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy * Exclusion Criteria: * the patients with kidney failure, liver failure, valvular and ischemic heart disease , high blood pressure, diabetes, history of infection and malignancy. * history of coagulation diseases, and history of drug allergies to used drugs. * those who consumed NSAIDs and analgesics 24 h before surgery were excluded from the study.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Al-Azhar University Asyut Egypt Recruiting
Al-Azhar University Asyut Egypt Not Yet Recruiting

More Al-Azhar University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06665438 on ClinicalTrials.gov ↗ ← All trials in Egypt